Fig. 10From: Mesoporous polydopamine delivering 8-gingerol for the target and synergistic treatment to the spinal cord injuryAssessment of adverse reactions: A-H levels of BUN, Cr, UA, ALT, AST, LDH, CK, and CKMB in different treatment groups after 14 days of drug treatment. I H&E staining was performed on the heart, liver, spleen, lung and kidney in different treatment groups after 56 days of drug treatment (Scale bar = 100 μm)Back to article page